All Stories

  1. catena-Poly[[bis[tris(4-methoxyphenyl)phosphine-κP]silver(I)]-μ-thiocyanato-κ2 N:S]
  2. (Nitrito-κ2 O:O′)bis[tris(4-fluorophenyl)phosphine-κP]silver(I)
  3. (Nitrito-κ2 O,O′)bis[tris(4-methylphenyl)phosphane-κP]silver(I)
  4. Tris(benzyldiphenylphosphane-κP)(nitrato-κO)silver(I)
  5. Bis[(4-methylphenyl)diphenylphosphane-κP](nitrato-κ2 O,O′)silver(I)
  6. catena-Poly[[(benzyldiphenylphosphine-κP)silver(I)]-μ-nitrato-κ2 O:O′-[(benzyldiphenylphosphine-κP)silver(I)]-μ-nitrato-κ4 O,O′:O′,O
  7. Bis[(4-methylphenyl)diphenylphosphine-κP](nitrito-κ2 O,O′)silver(I)
  8. Determination of maximum loading capacity of polyamidoamine (PAMAM) dendrimers and evaluation of Cu55 dendrimer-encapsulated nanoparticles for catalytic activity
  9. Dendrimers as alternative templates and pore-directing agents for the synthesis of micro- and mesoporous materials
  10. A Comparison of the Toxicity of Mono, Bis, Tris and Tetrakis Phosphino Silver Complexes on SNO Esophageal Cancer Cells
  11. Kinetic and catalytic analysis of mesoporous metal oxides on the oxidation of Rhodamine B
  12. Promotion effects of alkali- and alkaline earth metals on catalytic activity of mesoporous Co 3 O 4 for 4-nitrophenol reduction
  13. Kinetic and catalytic analysis of mesoporous Co 3 O 4 on the oxidation of morin
  14. Effective Catalytic Reduction of Methyl Orange Catalyzed by the Encapsulated Random Alloy Palladium-Gold Nanoparticles Dendrimer.
  15. Au and Ag nanoparticles encapsulated within silica nanospheres using dendrimers as dual templating agent and their catalytic activity
  16. Anticancer activity of silver(I) cyclohexyldiphenylphosphine complexes toward SNO cancer cells
  17. Synergistic Effects of Gold–Palladium Nanoalloys and Reducible Supports on the Catalytic Reduction of 4-Nitrophenol
  18. Confinement effect of rhodium(I) complex species on mesoporous MCM-41 and SBA-15: effect of pore size on the hydroformylation of 1-octene
  19. Random alloy nanoparticles of Pd and Au immobilized on reducible metal oxides and their catalytic investigation
  20. Synthesis of new ruthenium(II) complexes derived from labile nitrile ligands: an alternative route to the preparation of trans-dichlorotetrakis(diphenylphosphine)ruthenium(II)
  21. Selective liquid phase oxidation of benzyl alcohol to benzaldehyde by tert-butyl hydroperoxide over γ-Al2O3 supported copper and gold nanoparticles
  22. Apoptosis-inducing ability of silver(I) cyanide-phosphines useful for anti-cancer studies
  23. Crystal structure of methyl-2-methyl-4-(2-oxo-2-phenylethyl)-5-phenyl-1H-pyrrole-3-carboxylate, C21H19NO3
  24. Catalytic activity of mesoporous cobalt oxides with controlled porosity and crystallite sizes: Evaluation using the reduction of 4-nitrophenol
  25. Kinetics of the catalytic oxidation of morin on γ-Al 2 O 3 supported gold nanoparticles and determination of gold nanoparticles surface area and sizes by quantitative ligand adsorption
  26. One-pot reductive amination of carbonyl compounds with ammonia via ‘hydrogen borrowing’ using hydrido- and bis-ammine P,O(Me)-ruthenacycles
  27. Determination of the surface area and sizes of supported copper nanoparticles through organothiol adsorption—Chemisorption
  28. Synthesis of silver(I) p-substituted phenyl diphenyl phosphine complexes with the evaluation of the toxicity on a SNO cancer cell line
  29. Well-defined dendrimer encapsulated ruthenium SCILL catalysts for partial hydrogenation of toluene in liquid-phase
  30. “Cat in a bag” recycling of dendrimer encapsulated Au nanoparticles by use of dialysis membrane bag in the reduction of 4-nitrophenol: proof of heterogeneous catalysis
  31. Catalytic and kinetic investigation of the encapsulated random alloy (Pdn-Au110-n) nanoparticles
  32. Pt supported nitrogen doped hollow carbon spheres for the catalysed reduction of cinnamaldehyde
  33. Catalytic evaluation of dendrimer and reverse microemulsion template Pd and Pt nanoparticles for the selective oxidation of styrene using TBHP
  34. Catalytic oxidation of methylene blue by dendrimer encapsulated silver and gold nanoparticles
  35. Synthesis of narrowly dispersed silver and gold nanoparticles and their catalytic evaluation for morin oxidation
  36. The preparation of well-defined dendrimer-encapsulated palladium and platinum nanoparticles and their catalytic evaluation in the oxidation of morin
  37. Kinetic analysis of catalytic oxidation of methylene blue over γ-Al2O3 supported copper nanoparticles
  38. Synthesis and characterisation of silver(I) benzyldiphenylphosphine complexes: Towards the biological evaluation on SNO cells
  39. The dominant steric effect in the synthesis of ammine hydrido- and chlorido-Ru(II)-N,N-dimethylhydrazine and mixed alkyl–aryl phosphine complexes: Novel methyldiazene reduction intermediates
  40. Catalytic Behavior of Different Sizes of Dendrimer-Encapsulated AunNanoparticles in the Oxidative Degradation of Morin with H2O2
  41. The effect of 1:2 Ag(I) thiocyanate complexes in MCF-7 breast cancer cells
  42. Palladium Nanoparticles Supported on Mesoporous Silica as Efficient and Recyclable Heterogenous Nanocatalysts for the Suzuki C–C Coupling Reaction
  43. Synthesis and catalytic evaluation of dendrimer-templated and reverse microemulsion Pd and Pt nanoparticles in the reduction of 4-nitrophenol: The effect of size and synthetic methodologies
  44. Effects ofDaniella oliveriWood Flour Characteristics on the Processing and Functional Properties of Wood Polymer Composites
  45. Mechanism of fiber/matrix bond and properties of wood polymer composites produced from alkaline-treatedDaniella oliveriwood flour
  46. Catalytic activity of palladium and gold dendrimer-encapsulated nanoparticles for methylene blue reduction: A kinetic analysis
  47. Evaluation of catalytic activity of Ag and Au dendrimer-encapsulated nanoparticles in the reduction of 4-nitrophenol
  48. The induction of cell death by phosphine silver(I) thiocyanate complexes in SNO-esophageal cancer cells
  49. Preparation of well-defined dendrimer encapsulated ruthenium nanoparticles and their application as catalyst and enhancement of activity when utilised as SCILL catalysts in the hydrogenation of citral
  50. Fulvene–Ruthenium and Cp–Ruthenium Complexes via [2 + 2 + 1] Cyclotrimerization of Phenylacetylene with [RuCl(Tp)(1,5-cod)]
  51. Catalytic evaluation of dendrimer-templated Pd nanoparticles in the reduction of 4-nitrophenol using Langmuir–Hinshelwood kinetics
  52. Kinetic Evaluation of Dendrimer-Encapsulated Palladium Nanoparticles in the 4-Nitrophenol Reduction Reaction
  53. Synthesis of gold encapsulated in spherical carbon capsules with a mesoporous shell structure. A robust catalyst in a nanoreactor
  54. Reduction of 4-Nitrophenol as a Model Reaction for Nanocatalysis
  55. Mesoporous Materials as Potential Absorbents for Water Purification
  56. A new technique for the rapid characterization of catalysts: Tandem micro-reactor-gas chromatography/mass spectrometry
  57. Thermal stability of Ti–MCM-41
  58. The synthesis of silver phosphine phenyl derivatives for the use in cancer studies
  59. The synthetic investigation of novel Ru-based complexes and their application as catalysts in organic transformation reactions
  60. Synthetic Methodologies for Supported Ionic Liquid Materials
  61. Dendrimer-templated Pd nanoparticles and Pd nanoparticles synthesized by reverse microemulsions as efficient nanocatalysts for the Heck reaction: A comparative study
  62. Crystal structure of bis(phenylethynyl)tetrakis(dimethylphenylphosphine) ruthenium(II), C48H54P4Ru
  63. Synthesis and Antimicrobial Activity of New Schiff Base Compounds Containing 2-Hydroxy-4-pentadecylbenzaldehyde Moiety
  64. Biodiesel Production from Waste Vegetable Oils over MgO/Al2O3 Catalyst
  65. 4-[(2-Hydroxy-4-pentadecyl-benzylidene)-amino]-benzoic Acid Methyl Ester
  66. Preparation of Well-Defined Dendrimer Encapsulated Ruthenium Nanoparticles and Their Evaluation in the Reduction of 4-Nitrophenol According to the Langmuir–Hinshelwood Approach
  67. The effect of recrystallization time on pore size and surface area of mesoporous SBA-15
  68. Synthesis and X-ray studies of ruthenium(II) complexes containing hydrazine and benzyl isocyanide ligands
  69. Efficient and reusable Co/nitrogen doped hollow carbon sphere catalysts for the aerobic oxidation of styrene
  70. Pd on boron-doped hollow carbon spheres – PdO particle size and support effects
  71. Thermal stability of amine-functionalized MCM-41 in different atmospheres
  72. 5-Pentadecyl-2-((p-tolylimino)methyl)phenol
  73. Effect of calcination temperature and MgO crystallite size on MgO/TiO2 catalyst system for soybean oil transesterification
  74. Knoevenagel Condensation Reactions Catalysed by Metal-Organic Frameworks
  75. Dendrimer Derived Titania-Supported Au Nanoparticles as Potential Catalysts in Styrene Oxidation
  76. Expanding the synthesis of Stöber spheres: towards the synthesis of nano-magnesium oxide and nano-zinc oxide
  77. Synthesis, characterisation and in vitro evaluation of platinum(II) and gold(I) iminophosphine complexes for anticancer activity
  78. Synthesis and characterization of Cu, Ag and Au dendrimer-encapsulated nanoparticles and their application in the reduction of 4-nitrophenol to 4-aminophenol
  79. Synthesis, characterisation and in vitro evaluation of palladium(II) iminophosphine complexes for anticancer activity
  80. trans-Dichloridobis{dicyclohexyl[4-(dimethylamino)phenyl]phosphane-κP}platinum(II) dichloromethane disolvate
  81. 1-(Thiophen-2-yl)-N-(4-{(E)-[(thiophen-2-yl)methyl]iminomethyl}benzylidene)methanamine
  82. trans-Dichloridobis[dicyclohexyl(2,4,6-trimethylphenyl)phosphane-κP]palladium(II)
  83. cis-Dichloridobis[tris(4-chlorophenyl)phosphane-κP]platinum(II) acetonitrile monosolvate
  84. (Acetylacetonato-κ2 O,O′)carbonyl[dicyclohexyl(2,6-diisopropylphenyl)phosphane-κP]rhodium(I)
  85. trans-Dichloridobis[diphenyl(thiophen-2-yl)phosphane-κP]palladium(II)
  86. trans-Carbonylchloridobis[diphenyl(4-vinylphenyl)phosphane-κP]rhodium(I)
  87. (Acetylacetonato-κ2O,O′)carbonyl[tris(4-chlorophenyl)phosphane-κP]rhodium(I)
  88. trans-Bis[(2-bromophenyl)diphenylphosphane-κP]carbonylchloridorhodium(I)
  89. (Acetylacetonato-κ2O,O′)[(2-bromophenyl)diphenylphosphane-κP]carbonylrhodium(I)
  90. (Acetylacetonato-κ2O,O′)carbonyl[tris(naphthalen-1-yl)phosphane-κP]rhodium(I) acetone hemisolvate
  91. trans-Dichloridobis[dicyclohexyl(phenyl)phosphane-κP]palladium(II)
  92. Crystal Structure of (Cycloocta-1,5-diene)tris(hydrazine)hydrido-ruthenium(II) tetraphenylborate
  93. (Acetylacetonato-κ2O,O′)carbonyl{dicyclohexyl[4-(dimethylamino)phenyl]phosphane-κP}rhodium(I)
  94. cis-Bis(benzyldiphenylphosphane-κP)dichloridoplatinum(II) dichloromethane sesquisolvate
  95. cis-Dichloridobis[diphenyl(4-vinylphenyl)phosphane-κP]platinum(II)
  96. trans-Dichloridobis[diphenyl(4-vinylphenyl)phosphane-κP]palladium(II)
  97. (SP-4-2)-Chlorido{N-[2-(diphenylphosphanyl)benzylidene]benzylamine-κ2P,N}(methyl)palladium(II)
  98. Dichlorido[2-diphenylphosphanyl-N-(pyridin-3-ylmethyl)benzylidenamine-κ2P,N]platinum(II)
  99. Dichlorido{N-[2-(diphenylphosphanyl)benzylidene]-2,6-diisopropylaniline-κ2P,N}platinum(II)
  100. trans-Carbonylchloridobis[tris(naphthalen-1-yl)phosphane-κP]rhodium(I) acetone trisolvate
  101. Bis(acrylonitrile-κN)dichlorido(η4-cycloocta-1,5-diene)ruthenium(II)
  102. cis-Dichloridobis{[4-(dimethylamino)phenyl]diphenylphosphane-κP}platinum(II) ethyl acetate monosolvate
  103. Dichlorido(η4-cycloocta-1,5-diene)bis(propanenitrile-κN)ruthenium(II)
  104. trans-Carbonylchloridobis[dicyclohexyl(4-isopropylphenyl)phosphane]rhodium(I) acetone monosolvate
  105. Bis(acetonitrile-κN)dichlorido(η4-cycloocta-1,5-diene)ruthenium(II) acetonitrile monosolvate
  106. Triethylammonium hexa-μ2-acetato-κ12O:O′-diacetato-κ2O-aqua-μ3-oxido-triferrate(III) toluene monosolvate
  107. Dichlorido{N-[2-(diphenylphosphanyl)benzylidene]isopropylamine-κ2N,P}palladium(II) dimethyl sulfoxide monosolvate
  108. Bis[dicyclohexyl(phenyl)phosphane-κP]silver(I) perchlorate dichloromethane monosolvate
  109. 2-(Thiophen-2-yl)-N-(4-{(E)-[2-(thiophen-2-yl)ethyl]iminomethyl}benzylidene)ethanamine
  110. 1,4-Bis[(2-pyridylethyl)iminomethyl]benzene
  111. Characterization of [Rh(PhCOCHCOCH2CH2CH3)(CO)2] by X-ray crystallography, a computational and a statistical study
  112. Heterogenized Ru(II) phenanthroline complex for chemoselective hydrogenation of diketones under biphasic aqueous medium
  113. Ru(II) Phenanthroline Complex As Catalyst for Chemoselective Hydrogenation of Nitro-Aryls in a Green Process
  114. An efficient heterogeneous catalytic system for chemoselective hydrogenation of unsaturated ketones in aqueous medium
  115. trans-Dichloridobis{[4-(dimethylamino)phenyl]diphenylphosphane}palladium(II)
  116. trans-Dichloridobis[tris(4-methoxyphenyl)phosphane]palladium(II) toluene solvate
  117. Mechanism for the Formation of Substituted Manganese(V) Cyanidonitrido Complexes: Crystallographic and Kinetic Study of the Substitution Reactions oftrans-[MnN(H2O)(CN)4]2−with Monodentate Pyridine and Bidentate Pyridine−Carboxylate Ligands
  118. trans-Carbonylchloridobis[tris(4-chlorophenyl)phosphane]rhodium(I) acetone monosolvate
  119. Asymmetric activation of dialkyl zirconocenes
  120. Kinetics of thermal decomposition and of the reaction with oxygen, ethene and 1-octene of first generation Grubbs’ catalyst precursor
  121. Bis(dicyclohexylphenylphosphine)silver(I) nitrate
  122. Di-μ-thiocyanato-bis[bis(tri-p-tolylphosphine)silver(I)] 0.35-hydrate
  123. Concomitant polymorphic behavior of di-μ-thiocyanato-κ2 N:S;κ2 S:N-bis[bis(tri-p-fluorophenylphosphine-κP)silver(I)]
  124. Synthesis and characterization of [Ru3(CO)12−nLn] (L = P(OiPr)3;n= 1, 2, 3) and the “Star of David” disorder in bis- and tris-substituted products
  125. Equilibrium and kinetic studies of reactions of [MnN(H2O)(CN)4]2− with monodentate ligands and the molecular structure of [MnN(NCS)(CN)4]3−
  126. Isomorphism in monomeric 1:3 complexes of silver(I) salts with tri-p-tolylphosphine
  127. Bis(dicyclohexylphenylphosphine)iodidosilver(I) pyridine monosolvate
  128. Self-assembly in tetrameric 1:1 silver(I) halide:tri-p-tolylphosphine complexes: An in-depth structural investigation
  129. Di-μ-iodido-bis{[dicyclohexyl(phenyl)phosphine-κP](pyridine-κN)silver(I)}
  130. Polymorphism in iodotris(tri-p-tolylphosphine)silver(I)
  131. Coordination complexes of silver(I) with tertiary phosphine and related ligands
  132. Synthesis and characterization of an unusual equatorially substituted di-manganese compound. The first structural determination of a phosphite compound of type [Mn2(CO)9P]
  133. Synthesis and characterization of the substituted products from the reaction of a bulky phosphite with [Os3(CO)12]
  134. Reaction of a bulky phosphite with [Ru3(CO)12]: The molecular structure of one of the decomposition products
  135. [Butane-1,4-diylbis(nitrilodiethylidene)]tetraacetonitrile
  136. Di-μ-thiocyanato-bis[bis(tri-p-tolylphosphine)silver(I)] acetonitrile disolvate
  137. Low-temperature redetermination oftrans-tetrabromidobis(dimethyl sulfide-κS)platinum(IV)
  138. Acetatotris(triphenylarsine)silver(I) acetonitrile solvate monohydrate
  139. Tris(4-fluorophenyl)phosphine selenide
  140. Iodotris(tri-p-tolylphosphine)silver(I)
  141. A crystallographic and DFT study on Vaska-type trans-[Rh(CO)Cl(PR3)2] complexes containing flexible ligands: The molecular structure of trans-[Rh(CO)Cl{P(OC6H5)3}2]
  142. Di-μ-iodo-tris(tri-p-tolylphosphine)-1κP,2κ2P-dicopper(I)
  143. Tetrakis(tri-p-tolylphosphine-κP)silver(I) hexafluorophosphate
  144. Di-μ-iodo-bis[pyridine(tri-p-tolylphosphine)silver(I)]
  145. (p-Toluenesulfonato)tris(triphenylarsine)silver(I)
  146. Di-μ-acetato-bis[(tri-p-tolylphosphine)silver(I)]
  147. cis-Dichlorobis(tri-2-furylphosphine)palladium(II) dichloromethane hemisolvate
  148. Tetrakis(triphenylarsine)silver(I) hexafluorophosphate
  149. Tetra-μ3-iodo-tetrakis[(tri-p-tolylphosphine-κP)silver(I)]
  150. (η6-Benzene)dichloro[tris(2-isopropylphenyl) phosphite]ruthenium(II) dichloromethane solvate
  151. trans-Dichlorobis(tri-m-tolylphosphine)palladium(II)
  152. Novel Approach to Multimetal Metallaborane Clusters. Synthesis of Hypoelectronicnido-Cp*3IrRu2B5H9from the Reaction ofarachno-Cp*IrB3H9withnido-(Cp*RuH)2B3H7
  153. A new polymorph oftrans-carbonylchlorobis[tris(4-fluorophenyl)phosphine]rhodium(I)
  154. Di-μ2-chloro-bis[(benzyldiphenylphosphine)chloropalladium(II)]
  155. trans-Dichlorobis[tris(4-fluorophenyl)phosphine]palladium(II) toluene solvate
  156. trans-Bis(benzyldiphenylphosphine)carbonylchlororhodium(I)
  157. Lithiated dimethylaminomethyl ferrocenes and ruthenocenes
  158. Synthesis and characterisation of dialkyltin 2,3-bis(diphenylphosphino)maleic acid adducts
  159. Bis[bis(diphenylphosphino)ethane]rhodium(I) tetraphenylborate
  160. Carbonyl(8-hydroxyquinolinato)[tris(2-methylphenyl) phosphite]rhodium(I)
  161. Tertiary phosphine induced migratory carbonyl insertion in cyclopentadienyl complexes of iron(II)
  162. Carbonyl(8-hydroxyquinolinato)[tris(2,6-dimethylphenyl)phosphite]rhodium(I)
  163. New palladium α-diimine complexes containing dendritic wedges for ethene oligomerisation
  164. trans-Carbonylchlorobis[tris(pentafluorophenyl)phosphine)]rhodium(I)
  165. trans-Carbonylchlorobis(tri-m-tolylphosphino)rhodium(I) dichloromethane solvate
  166. Synthesis, Spectroscopy, and Hydroformylation Activity of Sterically Demanding, Phosphite-Modified Cobalt Catalysts
  167. New iron bis(imino)pyridyl complexes containing dendritic wedges for alkene oligomerisation
  168. trans-Carbonylchlorobis[tris(2-methylphenyl)phosphito]rhodium(I)
  169. Hydrozirconation of first-generation allyl-functionalized dendrimers and dendrimer model compounds
  170. Selective lithiation and crystal structures of G1-carbosilane dendrimers with dimethoxybenzene functionalities
  171. trans-Carbonylchlorobis[tris(2,6-dimethylphenyl)phosphito]rhodium(I)
  172. Chloromethylsilane functionalised dendrimers: synthesis and reactivity
  173. Synthesis, crystal structure and hydroformylation activity of triphenylphosphite modified cobalt catalysts
  174. Synthesis and Characterization of Lithiated Dendrimers
  175. Synthesis and antiplasmodial activity in vitro of new ferrocene–chloroquine analogues